Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript November 12, 2025
Immuneering Corporation misses on earnings expectations. Reported EPS is $-0.38 EPS, expectations were $-0.37.
Operator: Welcome to the Immuneering Corporation Conference Call to discuss the company’s Third Quarter 2025 financial results and share investigator-presented clinical case studies in pancreatic patients. At this time, all participants are in listen-only mode. Following management’s prepared...
